MIRA INFORM REPORT

 

 

Report Date :

26.07.2012

 

IDENTIFICATION DETAILS

 

Name :

REMEDICA HOLDINGS PUBLIC COMPANY LIMITED

 

 

Registered Office :

Industrial area, Limassol

 

 

Country :

Cyprus

 

 

Financials (as on) :

December 2009

 

 

Date of Incorporation :

08.04.1971

 

 

Com. Reg. No.:

C3559

 

 

Legal Form :

Public Limited Company

 

 

Line of Business :

Manufacture of pharmaceuticals, medicinal chemicals and botanical products

 

 

No. of Employees :

500 (Group)

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

Payment Behaviour :

Unknown

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2012

 

Country Name

Previous Rating

(31.12.2011)

Current Rating

(31.03.2012)

Cyprus

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

Basic Information

 

 

 

Registered Name

REMEDICA HOLDINGS PUBLIC COMPANY LIMITED

English Name

REMEDICA HOLDINGS PUBLIC COMPANY LIMITED

Registered Address

Industrial area, Limassol, Cyprus

Headquarters:

Acharnon, Lemesos, 3056, PoBox 51706, Limassol, Cyprus

Telephone

+35725392010 / +35725393444 / +35725530000

Fax

+35725390192

E-mail

info@remedica.com.cy , remedica@cytanet.com.cy

WebSite

www.remedica.com.cy

Legal Type

Public Limited Company

Registration No

C3559

Registration Date

08/04/1971

Last annual report

10/10/2003

Latest Annual Account Date

01/12/2010

Last return

17/05/2011

Tax Reg No:

VAT: CY 10003559

CINFO ID:

CYC11565575

 

 

 

    

 

 

Summary

Employees

July 2012

 

 

 

Company

Group

 

 

 

 

Total Number

0

500

 

 

 

 

 

 

Financial Summary

December 2010

December 2009

December 2008

 

EUR

EUR

EUR

Revenue Sales

18977440.00

11855906.00

13740911.00

Pre Tax Profit

4054425.00

4205958.00

4431771.00

Working Capital

9548702.00

7068360.00

5889680.00

Total Equity

22754327.00

20369285.00

19285996.00

Long Term Debts

 

 

 

Trend

-

-

-

Additional Info:

Legal Advisor: CHARALAMPOUS, KOUNTOURIS & CO, 10, Georgiou Gennadiou, Agathangelos Court, Off. 303, Limassol, Tel. 25364783.

Correspondence: P&D SECRETARIAL SERVICES LTD, P.O. Box: 50012, 3600, Limassol, Tel. 25871600.

Please Note That:

MICHAIL MARIA Is Alternate Director of PATTICHIS CHRISTAKIS.

ARISTOTELOUS ANTRI is Alternate Director of PATTICHIS CHARALAMPOS.

ELEFTHERIOU LOUKAS is Alternate Director of SAVVIDIS AIMILIOS.

PANIKOS G. SCHIZA Was Alternate Director Of MARGARITA PATTICHI (Appointed on 21/02/1976).

ANDREAS PEGLITZIS Was Alternate Director Of CHRISTAKIS PATTICHI (Appointed on 21/02/1976 and 08/10/1979).

TAKIS CHRISTODOULOU Was Alternate Director Of MARGARITA PATTICHI (Appointed on 21/09/1973 and 08/10/1979).

PANIKOS G. SXIZAS Was Alternate Director of CHRISTAKIS PATTICHI (Appointed on 21/09/1973).

Please Note That: SCHIZAS G. PANIKOS Was Deceased On 30/03/1989.

Please Note That: Financial Statements Submitted for the Year 2002.

 

 

 

Payment

 

 

 

 

 

 

 

 

Assessment:

Low Risk

Payment Habits:

NO COMPLAINTS

A check against all available information sources revealed that no late payment incidents against Subject Company exist.

 

Good for amount and terms of inquiry:

Yes

 

 

Commercial morality

Good

 

 

Financial strength

Good

 

Maximum credit

470,000.00 EUR

 

 

 

 

 

Business History

 

 

 

 

 

 

 

Date

Event Name

Old Value

New Value

01/01/2008

Authorised Capital Changed

30000000.00 CYP

51000000.00 EUR

01/01/2008

Issued Capital Changed

0.00 CYP

0.00 EUR

01/01/2008

PaidUp Capital Changed

8568089.80 CYP

14565752.66 EUR

01/01/2008

Asked Capital Changed

0.00 CYP

0.00 EUR

01/01/2008

Foreign Capital Changed

0.00 CYP

0.00 EUR

01/01/2008

Nominal Values of Shares Changed

0.20 CYP

0.34 EUR

01/01/2008

Partnership Capital Changed

0.00 CYP

0.00 EUR

01/01/2008

Declared Capital Changed

0.00 CYP

0.00 EUR

20/12/2000

Change of name

PATTICHIS CHEMICAL COMPANY LIMITED

REMEDICA HOLDINGS LIMITED

05/12/2000

Authorised Capital Increased

300000.00 CYP

30000000.00 CYP

05/12/2000

Shares number changed

0

42840449

05/12/2000

Paid Up Capital Increased

0.00 CYP

8568089.80 CYP

05/12/2000

Nominal number of shares Changed

300000

150000000

05/12/2000

Nominal Value of Shares Decreased

1.00 CYP

0.20 CYP

05/12/2000

Change of type

Limited Company

Public Limited Company

14/02/1989

Authorised Capital Increased

100000.00 CYP

300000.00 CYP

14/02/1989

Nominal number of shares Changed

0

300000

14/02/1989

Nominal Value of Shares Increased

0.00 CYP

1.00 CYP

30/04/1985

Authorised Capital Increased

50000.00 CYP

100000.00 CYP

08/04/1971

Change of name

REMEDICA HOLDINGS LIMITED

REMEDICA HOLDINGS PUBLIC COMPANY LIMITED

 

 

 

 

 

 

 

Previous Locations

 

 

 

 

 

Registered

From:

To:

1A, Kosti Palama, Limassol, , Cyprus,

08/04/1971

30/06/1972

 

Capital

 

 

 

Authorized Capital

51,000,000.00

EUR

Issued Capital

0.00

EUR

Nominal No Of Shares

150,000,000.00

 

Issued No Of Shares

42,840,449.00

 

Nominal value

0.34

EUR

Paid Up

14,565,752.66

EUR

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate Structure

 

 

 

 

 

Directors

Position

ActsAs

ID

Occupation

Age

Appointed

Other dir.

 

 

 

MARRIOT CHRISTOPHER

 

Director

 

 

Professor

 

06/12/2000

No

 

150 Stamford Str., Department Of Pharmacy, King's College London, Franklin-Wilkins Bldg, London, SE1 8WA, United Kingdom

 

Other Directorship:

 

No Information Found

 

 

 

 

 

Other Shareholding:

 

No Information Found

 

 

 

 

 

 

PATTICHIS CHRISTAKIS

 

Director

 

117645(ID)

Chemist

85

08/04/1971

Yes

 

10 Christou Christovasili, Limassol, 3091, Cyprus

 

Other Directorship:

 

 

 

Name

 

Registration Date

RegNo

Status

Position

Update Date

 

REMEDICA LIMITED

 

30/07/1980

C14435

Registered and operational

Director

30/11/2011

 

INTERPAK LIMITED

 

09/04/1971

C3562

Registered and operational

Director

17/01/2011

 

 

 

 

 

Other Shareholding:

 

 

 

Name

 

Registration Date

RegNo

Status

%

Update Date

 

INTERPAK LIMITED

 

09/04/1971

C3562

Registered and operational

0.05

17/01/2011

 

REMEDICA LIMITED

 

30/07/1980

C14435

Registered and operational

0.00033

30/11/2011

 

 

 

 

 

 

PATTICHI CHR. MARGARITA

 

Director

 

674491(ID)

Housewife

70

13/10/2003

Yes

 

10 Christou Christovasili, Limassol, 3091, Cyprus

 

Other Directorship:

 

 

 

Name

 

Registration Date

RegNo

Status

Position

Update Date

 

INTERPAK LIMITED

 

09/04/1971

C3562

Registered and operational

Director

17/01/2011

 

REMEDICA LIMITED

 

30/07/1980

C14435

Registered and operational

Director

14/01/2011

 

 

 

 

 

Other Shareholding:

 

No Information Found

 

 

 

 

 

 

PATTICHIS CHARALAMPOS

 

Director

 

633304(ID)

Chemist

48

23/10/1995

Yes

 

2 Giasemion, Germasogeia, 4043, Limassol, Cyprus

 

Other Directorship:

 

 

 

Name

 

Registration Date

RegNo

Status

Position

Update Date

 

SYNDESMOS VIOMICHANON PROTIS VIOMICHANIKIS PERIOCHIS LEMESOU

 

23/11/1995

C75453

Registered and operational

Director

17/10/2011

 

INTERPAK LIMITED

 

09/04/1971

C3562

Registered and operational

Director

17/01/2011

 

REMEDICA LIMITED

 

30/07/1980

C14435

Registered and operational

Director

14/01/2011

 

 

 

 

 

Other Shareholding:

 

No Information Found

 

 

 

 

 

 

MICHAIL MARIA

 

Alternate Director

 

586329(ID)

Biochemist

53

27/10/2006

No

 

10 Myronos, 3035, Limassol, Cyprus

 

Other Directorship:

 

No Information Found

 

 

 

 

 

Other Shareholding:

 

No Information Found

 

 

 

 

 

 

ARISTOTELOUS ANTRI

 

Alternate Director

 

464607(ID)

Accountant

60

27/10/2006

No

 

3A Chrysosotirou, Kato Polemidia, 4152, Limassol, Cyprus

 

Other Directorship:

 

No Information Found

 

 

 

 

 

Other Shareholding:

 

No Information Found

 

 

 

 

 

 

ELEFTHERIOU LOUKAS

 

Alternate Director

 

418096(ID)

Chemical Engineer

64

27/10/2006

No

 

5 Agias Varvaras, 3065, Limassol, Cyprus

 

Other Directorship:

 

No Information Found

 

 

 

 

 

Other Shareholding:

 

No Information Found

 

 

 

 

 

 

GAVRIIL GEORGIOS

 

Director

 

735358(ID)

Accountant

41

27/10/2006

No

 

12 Kalavardon Rodou, 7573, Anafotida, Larnaka, Cyprus

 

Other Directorship:

 

No Information Found

 

 

 

 

 

Other Shareholding:

 

No Information Found

 

 

 

 

 

 

SAVVIDES AIMILIOS

 

Director

 

435479(ID)

Employee

60

16/01/1982

Yes

 

33 Souliou, Limassol, 3016, Cyprus

 

Other Directorship:

 

 

 

Name

 

Registration Date

RegNo

Status

Position

Update Date

 

M.E.V.A. LEMESOU LIMITED

 

14/12/1994

C67378

Registered and operational

Director

01/08/2011

 

 

 

 

 

Other Shareholding:

 

No Information Found

 

 

 

 

 

 

 

 

 

Secretary

Position

ActsAs

ID

Occupation

Age

Appointed

Other dir.

 

 

 

P & D  SECRETARIAL SERVICES LIMITED

 

Company Secretary

 

C35673

 

0

10/06/1990

No

 

10 Georgiou Gennadiou, Agathangelos Court, 3rd Floor, Apt. 303, Limassol, 3041, Cyprus

 

Other Directorship:

 

No Information Found

 

 

 

 

 

Other Shareholding:

 

No Information Found

 

 

 

 

 

 

 

 

 

Shareholders

ID / Reg. No.

ActsAs

Nationality

Shares

%

Shares Breakdown

Class

Type

 

 

 

PATTICHIS CHARALAMPOS

 

633304(ID)

 

CYPRIOT

23802913

55.56177

-

-

-

 

 

2 Giasemion, Germasogeia, 4043, Limassol, Cyprus

 

Other Directorship:

 

 

 

Name

 

Registration Date

RegNo

Status

Position

Update Date

 

SYNDESMOS VIOMICHANON PROTIS VIOMICHANIKIS PERIOCHIS LEMESOU

 

23/11/1995

C75453

Registered and operational

Director

17/10/2011

 

INTERPAK LIMITED

 

09/04/1971

C3562

Registered and operational

Director

17/01/2011

 

REMEDICA LIMITED

 

30/07/1980

C14435

Registered and operational

Director

14/01/2011

 

 

 

 

 

Other Shareholding:

 

No Information Found

 

 

 

 

 

 

PATTICHI CHR. MARGARITA

 

674491(ID)

 

CYPRIOT

17768490

41.47597

-

-

-

 

 

10 Christou Christovasili, Limassol, 3091, Cyprus

 

Other Directorship:

 

 

 

Name

 

Registration Date

RegNo

Status

Position

Update Date

 

INTERPAK LIMITED

 

09/04/1971

C3562

Registered and operational

Director

17/01/2011

 

REMEDICA LIMITED

 

30/07/1980

C14435

Registered and operational

Director

14/01/2011

 

 

 

 

 

Other Shareholding:

 

No Information Found

 

 

 

 

 

 

PATTICHIS CHRISTAKIS

 

117645(ID)

 

CYPRIOT

1269038

2.96224

-

-

-

 

 

10 Christou Christovasili, Limassol, 3091, Cyprus

 

Other Directorship:

 

 

 

Name

 

Registration Date

RegNo

Status

Position

Update Date

 

REMEDICA LIMITED

 

30/07/1980

C14435

Registered and operational

Director

30/11/2011

 

INTERPAK LIMITED

 

09/04/1971

C3562

Registered and operational

Director

17/01/2011

 

 

 

 

 

Other Shareholding:

 

 

 

Name

 

Registration Date

RegNo

Status

%

Update Date

 

INTERPAK LIMITED

 

09/04/1971

C3562

Registered and operational

0.05

17/01/2011

 

REMEDICA LIMITED

 

30/07/1980

C14435

Registered and operational

0.00033

30/11/2011

 

 

 

 

 

 

SAVVIDES AIMILIOS

 

435479(ID)

 

CYPRIOT

2

0

-

-

-

 

 

23 Souliou, Limassol, 3016, Cyprus

 

Other Directorship:

 

 

 

Name

 

Registration Date

RegNo

Status

Position

Update Date

 

M.E.V.A. LEMESOU LIMITED

 

14/12/1994

C67378

Registered and operational

Director

01/08/2011

 

 

 

 

 

Other Shareholding:

 

No Information Found

 

 

 

 

 

 

PATTICHI KATERINA

 

633306(ID)

 

CYPRIOT

2

0

-

-

-

 

 

11 Christou Christovasili, Green House, Apt. 302, Limassol, 3091, Cyprus

 

Other Directorship:

 

No Information Found

 

 

 

 

 

Other Shareholding:

 

No Information Found

 

 

 

 

 

 

ARISTOTELOUS ANTRI

 

464607(ID)

 

CYPRIOT

2

0

-

-

-

 

 

3A Chrysosotirou, Kato Polemidia, Limassol, Cyprus

 

Other Directorship:

 

No Information Found

 

 

 

 

 

Other Shareholding:

 

No Information Found

 

 

 

 

 

 

PATTICHI CHRISTIANA

 

674535(ID)

 

CYPRIOT

2

0

-

-

-

 

 

11 Christou Christovasili, Green House, Atp. 101, Limassol, 3091, Cyprus

 

Other Directorship:

 

No Information Found

 

 

 

 

 

Other Shareholding:

 

No Information Found

 

 

 

 

 

Operation

 

 

 

 

 

 

 

Activity Code

Description

NACE 1.1

24.4

Manufacture of pharmaceuticals, medicinal chemicals and botanical products

 

NACE 2.1

2120

Manufacture of pharmaceutical preparations - This class includes: - manufacture of medicaments: > antisera and other blood fractions > vaccines > diverse medicaments, including homeopathic preparations - manufacture of chemical contraceptive products for external use and hormonal contraceptive medicaments - manufacture of medical diagnostic preparations, including pregnancy tests - manufacture of radioactive in-vivo diagnostic substances - manufacture of biotech pharmaceuticals - This class also includes: - manufacture of medical impregnated wadding, gauze, bandages, dressings etc. - preparation of botanical products (grinding, grading, milling) for pharmaceutical use - This class excludes: - manufacture of herb infusions (mint, vervain, chamomile etc.), see 10.83 - manufacture of dental fillings and dental cement, see 32.50 - manufacture of bone reconstruction cements, see 32.50 - manufacture of surgical drapes, see 32.50 - wholesale of pharmaceuticals, see 46.46 - retail sale of pharmaceuticals, see 47.73 - research and development for pharmaceuticals and biotech pharmaceuticals, see 72.1 - packaging of pharmaceuticals, see 82.92

 

 

 

 

 

 

 

 

 

 

 

 

 

Line of Business

The company in question was established in order to get involved with the development, production (100%) and trade on a wholesale basis (100%) of pharmaceutical products for human consumption such as tablets, powders, capsules, liquids, aerosols, pessaries etc.

The company imports around 90% of raw materials and exports 90% of their production in more than 90 countries worldwide through a selective network of representatives. They also maintain 4 vehicles for Distribution activities (the group maintains 20 vehicles).

The company's product range includes therapeutic categories such as antibiotics, analgesics, cardiovascular drugs, CNS agents, drugs for the GI tract, diuretics, antihistamines, antidiabetics, antiparkinsonian agents,
hormones and synthetic substitutes, vitamins, cough medicines and expectorants, and more. They produce a variety of pharmaceutical dosage forms, including tablets, capsules, creams, ointments, aerosols, pessaries,
suppositories, liquids, powders.

 

 

 

 

 

 

 

 

 

 

 

 

Export to

Percentage

 

 Australia, Denmark, Germany, United Kingdom, New Zealand

 

 

Comments

and to Eastern Europe, Africa, Asia

 

 

 

 

 

 

 

 

 

 

 

 

 

Export Terms

Percentage

 

Special agreements

 

 

 

 

 

 

 

 

 

 

 

 

 

Import from

Percentage

 

 China, India

 

 

Comments

and from Europe

 

 

 

 

 

 

 

 

 

 

 

Import Terms

Percentage

 

Special agreements

 

 

 

 

 

 

 

 

 

 

 

 

Market Terittory

 

 

 

 

 

 

Local Presence:

10%

International Presence

90%

 

 

 

 

 

 

 

 

 

 

Premises

 

 

 

 

 

 

 

 

Type

headquarters

 

Address:

Acharnon, Lemesos, 3056, PoBox 51706, Limassol, Cyprus

 

Headquarters comprise of

Offices, Factory, Warehouse

 

Headquarters operate as:

shared with affiliated company

 

 

 

 

 

 

 

 

 

 

 

 

Banks

 

BANK OF CYPRUS PUBLIC COMPANY LIMITED

 

51 Stasinou, Agia Paraskevi, Strovolos, 2002, Nicosia, Cyprus

 

CYPRUS POPULAR BANK PUBLIC CO LTD

 

39 Archiepiskopou Makariou C' Avenue, 2025, Nicosia, Cyprus

 

PIRAEUS BANK (CYPRUS) LIMITED

 

Cyprus

 

 

 

 

 

 

 

 

 

 

 

 

Affiliates and Subsidiares

Relation

Year Reg.

 

REMEDICA LIMITED

Subsidiary

1980

 

Acharnon, Lemesos, 3056, PoBox 51706, Limassol, Cyprus

 

M.E.V.A. LEMESOU LIMITED

Affiliate

1994

 

Acharnon, Lemesos, 3056, PoBox 51294, Limassol, Cyprus

 

INTERPAK LIMITED

Subsidiary

1971

 

Acharnon, Industrial Area, 3056, Limassol, Cyprus

 

Chr. Pattichis Investments Limited

Affiliated Company

 

 

 

 

M.E.V.A. LEMESOU LIMITED

Affiliated Company

 

 

 

 

 

Charges

 

 

 

 

 

 

 

 

 

 

 

No

Date registered

Date prepared

Type

Description/No

Amount

Sequence

Beneficiary

0

N/A

N/A

N/A

N/A

N/A

N/A

No charges found

 

 

 

 

 

 

 

 

 

 

Charges History

 

 

 

 

 

 

 

No

Date registered

Date prepared

Date End

Type

Description/No

Amount

Sequence

Beneficiary

1

03/05/1983

14/04/1983

21/09/1994

Fixed Charge on the Company's Machinery

 

75,000.00 CYP

-

Bank of Cyprus Public Company Limited

2

30/09/1980

18/09/1980

21/09/1994

Mortgage

Y2758/80

15,000.00 CYP

-

Bank of Cyprus Public Company Limited

3

12/12/1977

02/12/1977

08/03/1979

Mortgage

Y3120/77

15,000.00 CYP

-

Bank of Cyprus Public Company Limited

4

03/02/1977

01/02/1977

18/09/1980

Mortgage

Y181/77

15,000.00 CYP

-

Bank of Cyprus Public Company Limited

5

28/06/1972

17/06/1972

09/05/1979

-

First Fixed Charge On The Company's Machinery And Equipment

17,000.00 CYP

-

Cyprus Development Bank Limited

6

28/06/1972

17/06/1972

06/03/1979

Mortgage

Y2048/72

17,000.00 CYP

-

Cyprus Development Bank Limited

 

 

Negatives

No negative data

 

 

Financial Statement

 

 

Corporate financial statement

Financial Figures are Individual

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance Sheet

December  2010

December  2009

December  2008

 

EUR

EUR

EUR

 

 

FIXED ASSETS

 

 

 

Property, plant and equipment

1152757

1248057

1343448

Investment in associates

12052868

12052868

12052868

Total fixed assets

13205625

13300925

13396316

CURRENT ASSETS

 

 

 

Inventories

33880

146239

 

Trade and other receivables

6813195

8229357

5989148

Cash and cash equivalents

3889875

4001278

4011400

Total current assets

10736950

12376874

10000548

Total assets

23942575

25677799

23396864

CAPITAL AND RESERVES

 

 

 

Share capital

14565753

14565753

14565753

Other reserves

73698

73698

73698

Retained earnings

8114876

5729834

4646545

Total equity

22754327

20369285

19285996

LONG-TERM LIABILITIES

 

 

 

Total long-term liabilities

0

0

0

CURRENT LIABILITIES

 

 

 

Trade and other payables

1154897

5111563

3566768

Current income tax liabilities

9868

196951

544100

Bank overdraft

23483

 

 

Total Current Liabilities

1188248

5308514

4110868

Total liabilities

1188248

5308514

4110868

Total equity and liabilities

23942575

25677799

23396864

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Profit/Loss Account

December  2010

December  2009

December  2008

 

EUR

EUR

EUR

 

 

 

 

 

Sales

18977440

11855906

13740911

Cost of goods sold

16489734

9621232

11169403

Gross profit

2487706

2234674

2571508

Other Operating income

2123265

3330000

2837640

Selling and distribution expenses

711286

934920

748868

Administrative expenses

364649

390753

349391

OPERATING PROFIT/LOSS

3535036

4239001

4310889

Finance Income

519389

 

 

Finance costs

 

33043

120882

Profit/Loss before income tax

4054425

4205958

4431771

Income tax expense

169968

123838

151049

Profit/Loss for the year

3884457

4082120

4280722

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Key Ratios

December  2010

December  2009

December  2008

 

 

 

 

PROFITABILITY RATIOS

Gross Profit margin on sales

0.13

0.19

0.19

Return on assets (ROA)

0.20

0.34

0.31

LIQUIDITY RATIOS

Current Ratio

9.04

2.33

2.43

TURNOVER RATIOS

Sales to Net Working Capital Ratio

1.99

1.68

2.33

Total assets turnover (times)

0.79

0.46

0.59

 

 

 

 

Additional Information

 

 

MAIN SOURCES OF INFORMATION - FOR THIS REPORT

i. Visited Official Companies’ Registry

ii. Interview with Company / Correspondence

iii. Desk Research

iv. Search through Internet Subscription Databases (Business Information)

v. Specialized Media Search Global & Local

vi. Search through internet Social Networks

vii. Negative Record Database

viii. Relationship/Directorship Search through Database

The company in question was established in order to get involved with the development, production (100%) and trade on a wholesale basis (100%) ofpharmaceutical products for human consumption such as tablets, powders, capsules, liquids, aerosols, pessaries etc.

We contacted the company in question and talked to Mr Michalis Cocconis, financial controller, who confirmed the details of this report. He also provided us with the draft accounts of 2010.

Please note that according to Mr Cocconis, finacial statements ofyear 2010 - 2011 will be audited by the end of August 2012. Reportedly, the Sales turnover for the year 2010 was approximately 18,9 million Euro.

A check against our records revealed that no negative payment incidents against Subject Company, such as unpaid invoices, dishonored cheques and utility bills, bankruptcies exist etc.

COUNTRY DEVELOPMENTS:

On 13 June 2012, Moody’s Investor Service once again downgraded Cyprus’s government bond ratings by two notches to Ba3 from Ba1 and research is now being carried out for further possible downgrade. The Cypriot banks’ exposure to Greece totals 29 billion Euros, or 160% of GDP, including both Greek government bonds and loans to Greek residents. As a result, it is expected that an increase of support by the government may have to be offered to the Cypriot banks due to their exposure to the Greek government and economy and Moody’s will be reflecting these in the Cypriot sovereign ratings.

On 25 June 2012 Financial Mirror published that, Cyprus has applied for the European bailout fund due to its need of 1.8 billion Euros to recapitalize its second largest lender, Cyprus Popular Bank. Stefanos Stefanou, a government spokesman, said that negotiations are yet to be made to determine the precise amount of money which will be lent to Cyprus. He also noted that despite the aid request from the EU, the Cypriot government will continue seeking for a loan from a country outside the EU, such as China and Russia, needed to help cover its budget deficit (2011 deficit: 6.3% of GDP, one of the highest in the Eurozone).

The country has already borrowed 2.5bn euros from Russia, whose business people are important customers of Cyprus's relatively large offshore financial sector which offers low tax rates. If Russia accepts to supply another loan with a low interest rate then Cyprus may be more willing to borrow the money to cover their refinancing needs from Russia instead of the EU.On 25 June 2012 Fitch announced a downgrade of Cyprus’s rating by one notch from BBB- to BB+; a decision due to Cyprus’s heavy exposure to the Greek economy. Cyprus is keen to protect its low 10% corporate taxation rate which makes it an attractive base for foreign companies.

The government is reluctant to acquire loans from the EU due to fear of further austerity measures placed, which may obstruct corporations from situating themselves in Cyprus. (End of Country Developments)

 

 

 

 

 

 

Contact Information

 

 

 

 

 

 

Name:

Mr Michalis Cocconis

 

Quality:

company

Area:

financial

 

Title:

controller

 

 

 

Confirm general details

 

 

 

 

 

 

 

News

 

 

www.remedica.com.cy

27/06/2008

 

Remedica receives the Cyprus Export Award for 2004 for its contribution to Cyprus industry.

 

 

www.remedica.com.cy

08/06/2007

 

Remedica has successfully entered many foreign markets, including countries of the European Union, Central and Eastern Europe, the Far East, the Middle East, Africa, and others.

 

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.56.37

UK Pound

1

Rs.87.44

Euro

1

Rs.68.04

 

 

INFORMATION DETAILS

 

Report Prepared by :

PRL

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.